Literature DB >> 10097678

Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?

A Bauernfeind1, Y Chong, K Lee.   

Abstract

The dogma that ampC genes are located exclusively on the chromosome was dominant until about 10 years ago. Since 1989 over 15 different plasmid-encoded AmpC beta-lactamases have been reported from several countries. Most of these enzymes evolved in two clusters. The major cluster includes several enzymes with a high similarity to CMY-2, which is the closest related chromosomal AmpC enzyme of Citrobacter freundii. A second cluster centers around CMY-1. It is less homogeneous and not closely related chromosomal AmpC enzymes. Molecular diversification by amino acid substitutions does not usually translate into a change in the resistance phenotype. At this time, CMY-2 appears to be the most prevalent and widely distributed. Further global increase of prevalence and diversity of plasmidic AmpC beta-lactamases have to be anticipated in the next millenium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10097678     DOI: 10.3349/ymj.1998.39.6.520

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  28 in total

1.  A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; H Sahly; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 3.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Development of a TaqMan multiplex PCR assay for detection of plasmid-mediated ampC β-lactamase genes.

Authors:  Chelsie N Geyer; Mark D Reisbig; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

7.  A structural view of the antibiotic degradation enzyme NDM-1 from a superbug.

Authors:  Yu Guo; Jing Wang; Guojun Niu; Wenqing Shui; Yuna Sun; Honggang Zhou; Yaozhou Zhang; Cheng Yang; Zhiyong Lou; Zihe Rao
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

8.  Identification of genotypes of plasmid-encoded AmpC beta-lactamases from clinical isolates and characterization of mutations in their promoter and attenuator regions.

Authors:  Gui-Ling Li; Li-Bo Duo; Ying Luan; Cheng-Ying Wang; Wei-Ping Wang; He-Guang Zhang; Qi Sun; Gui-Yun Qi
Journal:  Gene Expr       Date:  2012

9.  Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC beta-lactamases in Korean respiratory isolates of Klebsiella pneumoniae.

Authors:  Jong Hwa Yum; Shinyoung Kim; Hyukmin Lee; Dongeun Yong; Kyungwon Lee; Sang-Nae Cho; Yunsop Chong
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

10.  Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.

Authors:  Kyungwon Lee; Sook-Jin Jang; Hee-Joo Lee; Namhee Ryoo; Myungshin Kim; Seong-Geun Hong; Yunsop Chong
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.